Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort
2018; BMJ; Volume: 78; Issue: 7 Linguagem: Inglês
10.1136/annrheumdis-2018-214434
ISSN1468-2060
AutoresArielle Mendel, Sasha B Bernatsky, John G. Hanly, Murray B. Urowitz, Ann E. Clarke, Juanita Romero‐Díaz, Caroline Gordon, Sang‐Cheol Bae, Daniel J. Wallace, Joan T. Merrill, Jill P. Buyon, David Isenberg, Anisur Rahman, Ellen M. Ginzler, Michelle Petri, Mary Anne Dooley, Paul R. Fortin, Dafna D. Gladman, Kristján Steinsson, Rosalind Ramsey‐Goldman, Munther A. Khamashta, Cynthia Aranow, Meggan Mackay, Graciela S. Alarcón, Susan Manzi, Ola Nived, Andreas Jönsen, Asad Zoma, Ronald van Vollenhoven, Manuel Ramos‐Casals, Guillermo Ruiz‐Irastorza, Sam Lim, Kenneth Kalunian, Murat İnanç, Diane L. Kamen, Christine A. Peschken, Søren Jacobsen, Anca Askanase, Jorge Sánchez‐Guerrero, Ian N Bruce, N. Costedoat‐Chalumeau, Évelyne Vinet,
Tópico(s)Cardiovascular Issues in Pregnancy
ResumoTable 1 Characteristics of SLE pregnancies overall and according to aspirin use Characteristic All pregnant visits (n=475)* Pregnant visits with aspirin (n=121) Pregnant visits without aspirin (n=354) Patient characteristic Age, mean (SD) 31.0 (4.9) 30.5 (4.6) 31.2 (5.0) Ethnicity, n (%) Asian 66 (14) 7/66 (11) 59/66 (89) Native North American 3 (1) 2/3 (67) 1/3 (33) Black 88 (19) 9/88 (10) 79/88 (90) Caucasian 209 (44) 71/209 (34) 138/209 (66) Hispanic 62 (13) 20/62 (32) 42/62 (68) Indian subcontinent 25 (5) 8/25 (32) 17/25 (68) Other 22 (5) 4/22 (18) 18/22 (82) Country, n (%)
Referência(s)